Topical Infliximab in Eyes With Penetrating Keratoplasty
Status:
Not yet recruiting
Trial end date:
2023-03-01
Target enrollment:
Participant gender:
Summary
Penetrating keratoplasty is a cornea surgery involving several inflammatory complications, of
which the most important is glaucoma. Researchers wish to determine whether it is safe to
administer infliximab (an anti-inflammatory drug) eye drops after surgery, and whether this
eye drop could prevent the occurrence of glaucoma.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Centre hospitalier de l'Université de Montréal (CHUM)
Collaborators:
Fonds de recherche en ophtalmologie de l'Université de Montréal Maisonneuve-Rosemont Hospital Niagara Health System Ottawa Hospital Research Institute Prism Eye Institute